Why Shares of EyePoint Pharmaceuticals Were Rising Monday

Why Shares of EyePoint Pharmaceuticals Were Rising Monday

Submitted by admin on September 11, 2023 - 6:36pm
Source: 
Motley Fool
News Tags: 
Eyepoint
clinical trials
EYP-1901
diabetic retinopathy
Headline: 
Why Shares of EyePoint Pharmaceuticals Were Rising Monday
snippet: 
  • EyePoint reported top-line data on two phase 2 trials for its lead pipeline candidate.
  • The company focuses on serious eye disorders.
  • It said it has enough cash to fund operations into 2025

 

Do Not Allow Advertisers to Use My Personal information